NOV INC (NOV) Fundamental Analysis & Valuation

NYSE:NOVUS62955J1034

Current stock price

19.03 USD
-0.15 (-0.78%)
Last:

This NOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NOV Profitability Analysis

1.1 Basic Checks

  • NOV had positive earnings in the past year.
  • NOV had a positive operating cash flow in the past year.
  • NOV had positive earnings in 4 of the past 5 years.
  • NOV had a positive operating cash flow in 4 of the past 5 years.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.28%, NOV is in line with its industry, outperforming 42.62% of the companies in the same industry.
  • NOV has a Return On Equity (2.31%) which is comparable to the rest of the industry.
  • NOV has a Return On Invested Capital (4.29%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NOV is significantly below the industry average of 13.21%.
Industry RankSector Rank
ROA 1.28%
ROE 2.31%
ROIC 4.29%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.46%
ROE(5y)5.28%
ROIC(3y)4.81%
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • The Profit Margin of NOV (1.66%) is comparable to the rest of the industry.
  • NOV's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.47%, NOV is in line with its industry, outperforming 49.18% of the companies in the same industry.
  • NOV's Operating Margin has improved in the last couple of years.
  • The Gross Margin of NOV (21.03%) is worse than 60.66% of its industry peers.
  • In the last couple of years the Gross Margin of NOV has grown nicely.
Industry RankSector Rank
OM 7.47%
PM (TTM) 1.66%
GM 21.03%
OM growth 3Y28.51%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y24.49%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

7

2. NOV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NOV is destroying value.
  • NOV has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NOV has been reduced compared to 5 years ago.
  • The debt/assets ratio for NOV has been reduced compared to a year ago.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.07 indicates that NOV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.07, NOV perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
  • The Debt to FCF ratio of NOV is 2.26, which is a good value as it means it would take NOV, 2.26 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.26, NOV is in the better half of the industry, outperforming 73.77% of the companies in the same industry.
  • NOV has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.31, NOV is doing good in the industry, outperforming 63.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.26
Altman-Z 2.07
ROIC/WACC0.57
WACC7.49%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • NOV has a Current Ratio of 2.42. This indicates that NOV is financially healthy and has no problem in meeting its short term obligations.
  • NOV's Current ratio of 2.42 is fine compared to the rest of the industry. NOV outperforms 73.77% of its industry peers.
  • A Quick Ratio of 1.67 indicates that NOV should not have too much problems paying its short term obligations.
  • The Quick ratio of NOV (1.67) is better than 67.21% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.67
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. NOV Growth Analysis

3.1 Past

  • The earnings per share for NOV have decreased strongly by -64.72% in the last year.
  • The Earnings Per Share has been growing by 13.62% on average over the past years. This is quite good.
  • NOV shows a decrease in Revenue. In the last year, the revenue decreased by -1.42%.
  • Measured over the past years, NOV shows a small growth in Revenue. The Revenue has been growing by 7.50% on average per year.
EPS 1Y (TTM)-64.72%
EPS 3Y1.08%
EPS 5Y13.62%
EPS Q2Q%-105.37%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%

3.2 Future

  • NOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.19% yearly.
  • The Revenue is expected to grow by 1.27% on average over the next years.
EPS Next Y78.43%
EPS Next 2Y49.02%
EPS Next 3Y40.85%
EPS Next 5Y21.19%
Revenue Next Year-0.16%
Revenue Next 2Y1.57%
Revenue Next 3Y2.45%
Revenue Next 5Y1.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

6

4. NOV Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.39, NOV can be considered very expensive at the moment.
  • NOV's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.53. NOV is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 18.78, which indicates a rather expensive current valuation of NOV.
  • NOV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NOV is cheaper than 68.85% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NOV to the average of the S&P500 Index (37.95), we can say NOV is valued rather cheaply.
Industry RankSector Rank
PE 33.39
Fwd PE 18.78
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 77.05% of the companies listed in the same industry.
  • 95.08% of the companies in the same industry are more expensive than NOV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.83
EV/EBITDA 7.28
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • NOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOV's earnings are expected to grow with 40.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)2.45
EPS Next 2Y49.02%
EPS Next 3Y40.85%

5

5. NOV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.61%, NOV has a reasonable but not impressive dividend return.
  • NOV's Dividend Yield is a higher than the industry average which is at 0.99.
  • NOV's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

  • On average, the dividend of NOV grows each year by 59.82%, which is quite nice.
  • NOV has paid a dividend for at least 10 years, which is a reliable track record.
  • NOV has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)59.82%
Div Incr Years2
Div Non Decr Years5
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 131.03% of the earnings are spent on dividend by NOV. This is not a sustainable payout ratio.
  • The dividend of NOV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP131.03%
EPS Next 2Y49.02%
EPS Next 3Y40.85%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

NOV Fundamentals: All Metrics, Ratios and Statistics

NOV INC

NYSE:NOV (4/17/2026, 3:25:04 PM)

19.03

-0.15 (-0.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners106.28%
Inst Owner Change0.02%
Ins Owners0.47%
Ins Owner Change4.55%
Market Cap6.86B
Revenue(TTM)8.74B
Net Income(TTM)145.00M
Analysts71.67
Price Target20.63 (8.41%)
Short Float %7.17%
Short Ratio5.12
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend0.51
Dividend Growth(5Y)59.82%
DP131.03%
Div Incr Years2
Div Non Decr Years5
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.67%
Min EPS beat(2)-108.73%
Max EPS beat(2)-56.61%
EPS beat(4)0
Avg EPS beat(4)-48.37%
Min EPS beat(4)-108.73%
Max EPS beat(4)-2.37%
EPS beat(8)3
Avg EPS beat(8)-15.05%
EPS beat(12)5
Avg EPS beat(12)-8.02%
EPS beat(16)8
Avg EPS beat(16)25.57%
Revenue beat(2)2
Avg Revenue beat(2)2.29%
Min Revenue beat(2)0.65%
Max Revenue beat(2)3.93%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-0.85%
Max Revenue beat(4)3.93%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)8
Avg Revenue beat(12)0.71%
Revenue beat(16)12
Avg Revenue beat(16)1.34%
PT rev (1m)2.19%
PT rev (3m)20.63%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-16.32%
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-10.77%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 33.39
Fwd PE 18.78
P/S 0.78
P/FCF 7.83
P/OCF 5.48
P/B 1.09
P/tB 1.62
EV/EBITDA 7.28
EPS(TTM)0.57
EY3%
EPS(NY)1.01
Fwd EY5.33%
FCF(TTM)2.43
FCFY12.77%
OCF(TTM)3.47
OCFY18.24%
SpS24.26
BVpS17.39
TBVpS11.74
PEG (NY)0.43
PEG (5Y)2.45
Graham Number14.9348 (-21.52%)
Profitability
Industry RankSector Rank
ROA 1.28%
ROE 2.31%
ROCE 7.35%
ROIC 4.29%
ROICexc 5.2%
ROICexgc 7.19%
OM 7.47%
PM (TTM) 1.66%
GM 21.03%
FCFM 10.02%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.46%
ROE(5y)5.28%
ROIC(3y)4.81%
ROIC(5y)N/A
ROICexc(3y)5.57%
ROICexc(5y)N/A
ROICexgc(3y)7.61%
ROICexgc(5y)N/A
ROCE(3y)8.24%
ROCE(5y)N/A
ROICexgc growth 3Y30.92%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.35%
ROICexc growth 5YN/A
OM growth 3Y28.51%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y24.49%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.26
Debt/EBITDA 1.9
Cap/Depr 105.63%
Cap/Sales 4.29%
Interest Coverage 7.68
Cash Conversion 124.11%
Profit Quality 604.14%
Current Ratio 2.42
Quick Ratio 1.67
Altman-Z 2.07
F-Score5
WACC7.49%
ROIC/WACC0.57
Cap/Depr(3y)100.56%
Cap/Depr(5y)87.69%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.72%
EPS 3Y1.08%
EPS 5Y13.62%
EPS Q2Q%-105.37%
EPS Next Y78.43%
EPS Next 2Y49.02%
EPS Next 3Y40.85%
EPS Next 5Y21.19%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%
Revenue Next Year-0.16%
Revenue Next 2Y1.57%
Revenue Next 3Y2.45%
Revenue Next 5Y1.27%
EBIT growth 1Y-25.46%
EBIT growth 3Y36.88%
EBIT growth 5YN/A
EBIT Next Year60.92%
EBIT Next 3Y24.16%
EBIT Next 5Y13.14%
FCF growth 1Y-8.08%
FCF growth 3YN/A
FCF growth 5Y4.59%
OCF growth 1Y-4.06%
OCF growth 3YN/A
OCF growth 5Y6.2%

NOV INC / NOV Fundamental Analysis FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 5 / 10 to NOV.


Can you provide the valuation status for NOV INC?

ChartMill assigns a valuation rating of 6 / 10 to NOV INC (NOV). This can be considered as Fairly Valued.


How profitable is NOV INC (NOV) stock?

NOV INC (NOV) has a profitability rating of 4 / 10.


What is the financial health of NOV INC (NOV) stock?

The financial health rating of NOV INC (NOV) is 7 / 10.


Can you provide the dividend sustainability for NOV stock?

The dividend rating of NOV INC (NOV) is 5 / 10 and the dividend payout ratio is 131.03%.